New Ultrasound Memory Study
Join our groundbreaking research on ultrasound technology for memory enhancement. Help pioneer the future of cognitive wellness.
Learn About Study HereJoin our groundbreaking research on ultrasound technology for memory enhancement. Help pioneer the future of cognitive wellness.
Learn About Study HereIP-NFTs represent a paradigm shift in biotechnology ownership, breaking away from traditional models that concentrate medical intellectual property in the hands of a select few.
In the current system, those who take the greatest risks in medical advancement — the early adopters and test participants — often receive the least reward. Our IP-NFT model changes this fundamental imbalance.
Taxpayers fund research through public institutions, only to have the resulting innovations locked behind expensive paywalls.
Academic research, funded by public money, often gets trapped in restrictive tech transfer contracts, disconnecting researchers from their innovations.
Traditional pharma-biotech companies often apply massive markups, making treatments inaccessible to many who helped fund their development.
Early adopters receive lifetime ownership rights through IP-NFTs, ensuring they benefit from future success.
IP-NFT holders receive proportional benefits from any future sales or licensing of the technology.
IP-NFTs directly connect to physical Ultrasound devices, creating tangible value for holders.
On UltraDAO an IP-NFT isn't an abstract collectible — it's a specific therapeutic frequency, validated by research, that you own and can use on a real device.
A frequency profile is proven out in UltraDAO's clinical trials. The research comes first — see the active studies.
The validated frequency becomes an IP-NFT. Acquire it and you hold lifetime rights to that frequency plus a share of its upside.
Every IP-NFT carries a 7.5% royalty back to the DAO treasury — which funds the next trial, closing the loop.
Tap your phone to flash the frequency onto your PULSE device, spending $ULTRA to activate it. Ten minutes a day.
Join us in creating a more equitable future for medical innovation and treatment development.